Tiffany N Seagroves, PhD, MBA, PMP, School of Medicine
Our lab tests novel chemotherapy agents for safety and efficacy using a variety of cell-based and animal models of metastatic breast cancer. Novel compounds are first screened in vitro in a dose-dependent manner using live-cell imaging to measure changes in cell growth inhibition, cell viability, colony formation, wound healing, chemotaxis, and spheroid potential. Promising compounds are then moved to tumor-bearing animal models. Our research is currently supported by the NIH, the Department of Defense, and the Louisiana Cancer Research Center (LCRC).
| Faculty Supervisor | Tiffany N Seagroves, PhD, MBA, PMP |
| Project Start Date | 08/18/2025 |
| Number of Spots Available | 2 |
| Project Type | Basic Science |
| Location | On-Site |
| Type of Research | Animal-based, Lab-based, Data Analysis/Write-Up |
| Project Duration | Medium-term (1-3 years) |
| Supervisor | Faculty |
| Project Expertise | https://www.ncbi.nlm.nih.gov/myncbi/tiffany.seagroves.1/bibliography/public/ |
We are willing to train motivated students who are committed to contributing to our research program.
Minimum of 9h per week.
Please send a CV or resume to Dr. Seagroves, tseagroves@tulane.edu, and an unofficial transcript of coursework.
To apply for an opportunity, click here to login with your Tulane student ID.
